To study alterations of serum levels of the pancreatic reg family of proteins in two models of acute pancreatitis.
Summary Background Data
The pancreatic reg family of proteins is expressed in the acinar pancreas. Reg I (pancreatic stone protein, PSP) and reg III (pancreatitis-associated protein, PAP) are induced after the onset of acute pancreatitis, and both have been proposed as potential markers of pancreatitis.
Methods
Pancreatitis was induced in rats by either retrograde infusion of sodium taurocholate or by direct trauma. Serum samples were obtained daily for 4 days after the procedure, and the animals were then killed. Twelve animals underwent sham procedure and six underwent daily analysis without surgery. Levels of reg I/PSP and reg III/PAP were estimated by enzyme-linked immunosorbent assay.
Results
Reg III/PAP levels increased significantly the first day after induction of both types of pancreatitis and rapidly returned to baseline in all survivors. Even animals who received retrograde infusion of saline showed a mild increase in reg III/PAP on the first day, whereas control animals that did not undergo surgery showed no variations. Reg I/PSP serum levels remained unchanged throughout all experimental periods. Postinjury reg III/PAP levels significantly correlated with severity of the pancreatic injury and animal survival; reg I/PSP levels did not.
Conclusion
After induction of pancreatitis, serum levels of reg I and III protein differ significantly. Reg III/PAP levels are a sensitive marker of pancreatic injury and early in the disease may be a useful prognostic indicator for disease severity.
The pancreatic reg family of proteins is expressed in the gastrointestinal tract. Reg I␣, also known as pancreatic stone protein, is normally expressed in the acinar pancreas. Reg III, also known as pancreatitis-associated protein 1, was originally isolated from the pancreatic juice of rats with acute pancreatitis 1 and is normally expressed at low levels in pancreas, but reg III levels increase 200-to 300-fold after even mild pancreatic inflammation. [1] [2] [3] It has been characterized in humans and rats 1, 4 and is normally expressed in the small intestine 5, 6 and not in the pancreas. 7 Reg II has been described only in the mouse and rat. 7 Studies of acute pancreatitis in animals show that both reg I␣ and reg III genes (mRNAs) are induced in the parenchyma, 2, 8, 9 and serum levels of both proteins increase. 10, 11 Parenchymal levels of reg III/PAP-l have even been found to correlate with severity of pancreatic injury in rodents after induction by cerulein injection. 12 The fact that the reg genes are induced in the pancreatic parenchyma in graded response to injury makes them a potentially sensitive marker for injury and inflammation. Although reg III has been described as a potential marker for pancreatic injury in both pancreatitis 13 and pancreatic transplant, 14 no controlled comparison of serum reg I␣ and III levels in human or animal models of acute pancreatitis has been done.
The aim of this study was to compare the alterations of serum levels of reg I␣ and reg III proteins in rat models of acute pancreatitis. Two graded models of injury were used: infusion of sodium taurocholate (NaT) retrograde into the pancreatic duct, and a model of blunt pancreatic trauma. Serum levels of reg I and III were measured by enzymelinked immunosorbent assay (ELISA), and these were correlated with pancreatic injury and overall survival.
METHODS

Models of Pancreatitis
Twenty-six rats underwent retrograde infusion of NaT into the pancreatic duct. Under pentobarbital anesthesia (50 mg/kg given intraperitoneally), the duodenum was isolated and the main pancreatic duct was cannulated with polyethylene tubing (0.51 ID, 0.94 OD; Dow Corning, Midland, MI). Five, nine, and twelve animals underwent infusion of 2%, 3%, and 4% NaT, respectively. NaT was administered in 0.9% normal saline at a rate of 1 mL/kg during a period of 2 minutes. 15 Six animals underwent infusion of saline alone, and six served as nonoperated controls.
Eighteen rats were subjected to direct pancreatic trauma using a previously published protocol. 16 Briefly, a midline laparotomy was performed under anesthesia, and the neck and body of the pancreas was placed onto a platform. Controlled injury was applied by dropping a 52-g cylindrical weight from a distance of 12Љ, 18Љ, and 24Љ (n ϭ 6 per group). This induced a graded contusion injury of 0.156, 0.234, and 0.312 Joules. 16 Six animals underwent sham procedure.
The total number of animals used for all groups was 62. All surgical procedures were approved by the Animal Institute Committee at our institution, an accredited program.
Postoperative Analysis
Serum samples was obtained daily for 4 days after the procedure from tail veins. All surviving animals were killed on postinjury day 4, and necropsies were performed on all. The severity of pancreatitis at necropsy was graded by standardized scoring of gross tissue, as previously described. 16 Briefly, a normal-appearing pancreas was scored 0, edematous pancreatitis 1, moderate hemorrhagic/necrotic pancreatitis 2, and severe hemorrhagic/necrotic pancreatitis 3. The amount of ascites present at necropsy was also quantitated and scored as 0 mL, 0 to 5 mL, and greater than 5 mL. Serum amylase was measured by a enzymatic kit (Sigma, St. Louis, MO).
ELISA
Levels of reg I␣ (pancreatic stone protein) and reg III (PAP-I) were measured by direct competitive ELISA. Antibodies were produced in guinea pig to unique 10 -amino acid sequences of reg I and III, each at position 54 -63. 7 The sequences were reg I␣ ϭ YFMEDHLSWA and reg III ϭ ALFQIPQTWF. Each peptide was synthesized with the N-terminus linked to KLH (Research Genetics, Huntsville, AL) and antibodies raised in guinea pigs using Freund's adjuvant. Terminal bleeds were performed under anesthesia from the superior vena cava. 17 Stock solution of peptide were stored at 0.1 mg/mL in pH 7 solution in RPMI; for each ELISA, 0.01 mg/mL peptide was plated on 96-well plates. Plates were washed with blocking solution (Pierce, Rockford, MD) and then washed three times in phosphate-buffered saline (pH 7.0). Antibodies were used at 1:2,000 dilution for both standard curve and sample analysis. Rat serum was assayed at a 1:10 dilution and incubated overnight with antibody. After incubating each well with 100 L sample for 1 hour at room temperature, wells were washed three times with phosphate-buffered saline. Second antibody (1:2,000, alkaline phosphatase linked goat anti-guinea pig, Accurate Chemical & Scientific Co., Westbury, NY) was added for 30 minutes, and the plates were again washed with phosphate-buffered saline three times. Development was performed with ImmunoPure PNPP (Pierce, Rockford, IL), and absorbency was read at 415 nm on a microplate reader (Biorad, Gaithersville, MD).
Western Analysis
After SDS-polyacrylamide electrophoresis (15%), 10 g protein/well was electrophoretically transferred to nitrocellulose (Nytran; Schleicher & Schuell, Keene, NH) and polyclonal antibody was used at a 1:500 dilution. Antibody visualization was performed by alkaline phosphatase technique (NBT/BCIP, Pierce) using anti-IgG at a 1:15,000 dilution.
Statistical Analysis
Data are expressed as mean Ϯ standard error of the mean. All data were entered into a Statistica database (Statsoft, Tulsa, OK) and analyzed by analysis of variance with repeated measures, and pooled data were compared with controls by the unpaired Student t test. Post hoc comparisons were performed using the Newman-Keul test. Significance was defined as P Ͻ .05.
RESULTS
Antibodies and ELISA Construction
Western analysis of the reg I␣ antibody against pancreatic juice showed a band at 16 kD; Western analysis of the reg III antibody against small intestine showed a similar band ( Fig. 1A) . Both bands were inhibited by incubation with excess antigen (0.1 mg/mL, data not shown) and did not cross-react with human pancreatic juice or pure recombinant human PAP (Dynbio, Marseilles, France). The two antibodies generated reproducible ELISA standard curves, and a direct competitive ELISA was constructed. The limit of each ELISA was approximately 100 pg/mL on the standard curve and 500 pg/mL on rat serum. Standard curves for reg I␣ and reg III are shown in Figure 1B .
Mean reg I␣ and reg III levels for control animal serum were 2.5 Ϯ 0.2 g/mL and 366 Ϯ 75 ng/mL in the trauma group, respectively, and 2.25 Ϯ 0.98 g/mL and 224 Ϯ 57 ng/mL in the NaT group, respectively. The mean reg III level for all animals was 254 Ϯ 49 ng/mL. By comparison, data from rat pancreatic juice revealed a level of 68 Ϯ 11 g/mL, and 2.8 Ϯ 1 ng/mL, respectively.
Pancreatitis
Animals were subjected to graded pancreatic insult (2%, 3%, or 4% NaT) or 0.156, 0.234, or 0.312 Joules of blunt trauma. Hematoxylin-eosin staining of tissue at necropsy confirmed the presence of acute necrotizing pancreatitis in those that died, and resolving pancreatitis with infiltration of polymorphonuclear cells, zymogen-depleted acinar, and acinar atrophy in those that survived. Seven animals in the NaT group died; five in the trauma group died.
An upward trend in the death rate was noted for both groups as the pancreatic insult worsened; this was significant. Specifically, by scoring the severity of pancreatic injury as 0 for no operation, 1 for sham operation, and 2, 3, and 4 for increasing NaT (2%, 3%, or 4%) or trauma (0.156, 0.234, and 0.312 Joules), the correlation between injury and death was r ϭ 0.32 for the NaT group (P ϭ .046), r ϭ 0.404 for the trauma group (P ϭ .036), and r ϭ 0.315 for both groups (P ϭ .015). Figure 2 shows the percentage survival plotted against each group of injury severity, and an upward trend is seen.
For all animals studied, overall survival also significantly correlated with the necropsy-based pancreatic score (r ϭ 0.61, P Ͻ .001), fat score (r ϭ 0.67, P Ͻ .001), and amount of ascites (mL, r ϭ 0.88, P Ͻ .001).
All animals who died did so between day 1 and 2, allowing for determination of serum levels for those only on day 1 after surgery.
As shown in Figure 3A , serum amylase increased only with the most severe injury (from a baseline of 3,448 Ϯ 40 to 8,905 Ϯ 1,900 for 3% NaT on day 1, and 3,382 Ϯ 20 to 6,677 Ϯ 1,800 for 4% NaT, P Ͻ .05 vs. controls). Figure 3B shows that reg I␣ serum levels remained unchanged throughout all experimental periods. By comparison, reg III levels increased significantly on day 1 after induction of both types of pancreatitis (800 Ϯ 200% for NaT and 1,200 Ϯ 600% for trauma) and rapidly returned to baseline in all survivors (see Fig. 3C ). Even animals that underwent sham retrograde infusion of the pancreatic duct with saline showed a mild increase in reg III on the first day (NaT group, 1,744 Ϯ 1,200 ng/mL, p ϭ NS), whereas sham-operated controls showed no variations (control in trauma group). Figure 4 shows data of postinjury day 1 reg III levels for all groups compared with the pooled day 0 (preinjury) levels. All postinjury day 1 levels were increased significantly for the NaT infusions, but not for increasing trauma. There were significant differences in levels in both groups between survivors and nonsurvivors. In the NaT group, nonsurvivors had a reg III level of 2,490 Ϯ 1,000 ng/mL (P Ͻ .05 vs. baseline level and survivors on postinjury day 1, Student t test); in the trauma group, nonsurvivors had a reg III level of 2,651 Ϯ 350 ng/mL (P Ͻ .05 vs. baseline level and survivors on postinjury day 1). There was no graded level of reg III with increasing grade of injury. Also, absolute peak reg III levels did not significantly correlate with severity of the pancreatic injury or animal survival. Reg III levels were then compared with the gross scoring of pancreatitis severity performed at necropsy. There was a significant increase in reg III levels, the pancreatitis severity score, and ascites in animals that did not survive (Fig. 5 ).
Reg I and Reg III Serum Levels in Pancreatitis
There was also a significant correlation between serum reg III levels and severity of injury.
There was no correlation between the reg I and reg III serum levels (r ϭ 0.03, P ϭ .58), even if we compared levels only from day 0 and postinjury day 1. Similarly, there was no correlation between reg I levels and the necropsybased scoring described above (not shown).
DISCUSSION
Reg I␣ and reg III are proteins produced by the acinar cell of the pancreas in response to injury. Reg I is constitutively expressed; reg III is expressed only after injury. The expression of both genes increases after induction of pancreatitis, making both potential markers for severity of pancreatitis. To date, no study has measured levels of both in Although the reg family of proteins has been cloned and sequenced in rat, mouse, cow, and human, its function has yet to be determined. This family of secreted proteins has a strong resemblance to calcium-dependent lectins. 7 Reg I␣ was originally described 18 as "pancreatic stone protein", a protein that is a major component of pancreatic stones in patients with chronic calcific pancreatitis. Protein chemistry studies have shown that reg I␣ is a major exocrine product and its presence prevents calcium carbonate stone formation in normal pancreatic juice. 19, 20 This physiologic property has been localized to the amino-(N)-terminal 11 amino acids of the 166-amino acid molecule. As a result of this characteristic, the reg I␣ protein has also been named lithostatine. 21 In rat, reg I␣ has also been demonstrated in pancreatic juice, and its amino acid sequence is 68% identical to human. 7 It has been shown that reg I␣ is important in islet function 22 and ␤-cell regeneration. We have observed that reg I␣ gene expression correlates with ␤-cell function in models of aging, islet hyperplasia, and chronic There was a significant correlation between all measures of pancreatic injury and the level of reg III. This suggests that serum levels of the protein are a useful marker of pancreatic injury. Reg I␣ levels, however, did not correlate with severity of injury. (MeanϮstandard error of the mean, P Ͻ .05 vs. zero score or survivors.) pancreatitis. [23] [24] [25] [26] We have shown that human and rat reg I␣ proteins are mitogens to ductal and ␤-cells, implicating reg as a growth factor. 27 Reg III, 44% homologous to reg I␣, is not normally expressed in the pancreas but is constitutively expressed in small intestine. It is also known as pancreatitisassociated protein because its levels increase 200-to 300fold after the induction of pancreatitis. 1, 2, 4, 5, 8 Immediately after the induction of pancreatitis, the reg III protein localizes to the rough endoplasmic reticulum and fibrous material in the acinar lumen. 28 Although its function is unknown, reg III has been described as an acute phase reactant. 1 Iovanna et al 8 showed that reg III protein can promote bacterial aggregation, suggesting that it may be important in preventing bacterial growth after pancreatitis. Ortiz et al 29 recently reported that reg III may be a free radical scavenger that prevents apoptosis of acinar cells during pancreatitis. Our laboratory has shown that the bovine pancreatic thread protein, 65% homologous to rat reg III, is mitogenic to pancreatic-derived cells, 27 suggesting a function in the regeneration of the injured pancreas.
After the induction of acute pancreatitis, both reg I␣ and reg III genes are induced in the pancreatic parenchyma. 2, 8, 9 Their graded induction to graded injury makes them a potentially sensitive marker for pancreatic injury and inflammation. Although reg III has been described as a potential marker for pancreatic injury in both pancreatitis 10, 11, 13 and pancreatic transplant, 14 no controlled comparison of serum reg I␣ and III levels in human or animal models of acute pancreatitis has been done.
We used two models of graded pancreatic injury to determine the use of serum reg levels in acute pancreatitis. Using peptides unique to reg I␣ and reg III, we produced polyclonal antibodies in guinea pig and developed an ELISA for both reg I␣ and reg III in rat. Each antibody reacted with extract from tissue that normally expresses it (rat pancreatic juice for reg I␣ and intestine for reg III). Baseline serum levels of reg I␣ and III protein differ significantly. Because the amino acid sequences of each peptide differed significantly from human (by five amino acids for reg I␣ and by three for reg III), neither antibody crossreacted with human tissue (not shown).
We then studied the level of reg I␣ and reg III in the serum of animals after graded pancreatic injury, either chemical by retrograde infusion of NaT into the pancreatic duct or traumatic using a calibrated weight. Both models yielded increasing death rates with increased injury. A gross scoring system was used to compare severity of injury with reg I␣ and III levels. We observed that serum levels of reg III levels increased significantly after induction of pancreatitis, but reg I␣ levels did not.
After induction of pancreatitis, survival correlated well with severity of injury as well as severity of pancreatitis. Serum levels of reg III increased significantly even after mild injury, indicating that reg III was a sensitive marker of pancreatic injury. In fact, in control animals in which retrograde infusion of saline was given, a slight increase in reg III levels was noted. Light microscopic examination showed that these animals had mild pancreatitis, and they exhibited no elevation in serum amylase.
By contrast, serum levels of reg I␣ did not increase even after the most severe injury. This implies that reg III alone is a potential marker of the severity of pancreatitis.
Serum reg III levels peaked on postinjury day 1, which probably corresponds temporally to the peak expression of its gene and protein product. Further, postinjury day 1 levels of reg III correlated well with the overall death rate, the necropsy-observed pancreatic severity score, and the volume of ascitic fluid in the peritoneal cavity.
In both models, we expected postinjury deaths to be spread out over a period of 3 or 4 days, corresponding with increasing pancreatic injury. Unfortunately, we noted that most deaths occurred at postinjury day 1, and in most survivors reg III levels rapidly returned to normal.
We can therefore conclude that serum reg III levels are a useful marker of disease severity early (in the first 24 hours) in the disease. A better model would be to compare serum reg III levels with the pancreatic scores on postinjury day 1, and this is under way. We have compared the reg III levels on date of necropsy with pancreatic injury and noted a significant correlation (not shown).
A recent study in humans suggested that daily serum reg III levels could be used as a dynamic assessment of the severity of pancreatitis. 13 Those investigators noted that in patients with mild pancreatitis, reg III levels increase and rapidly decrease. In those with severe pancreatitis and subsequent complications, levels stay elevated. We could not confirm this observation experimentally, because complications and late death did not occur. We therefore cannot confirm the utility of reg III as a dynamic prognostic indicator of severity.
A reproducible model of complications or late death after pancreatitis is needed for better understanding of the predictive value of reg III serum levels. The choline-deficient diet plus ethionine model in mouse has a predictable rate of death and complications and may be a better model. The mouse sequences of reg I␣ and III are known, 7 so formulating a similar ELISA should be straightforward.
We conclude that serum levels of reg III are a sensitive marker of pancreatic injury, but reg I is not. This is the first study to examine the serum levels of two different members of the reg family simultaneously under experimental conditions of pancreatitis. Reg III is indeed a useful marker of pancreatitis and correlates well with severity and even survival. Reg III has potential as a prognostic indicator of severity of this devastating disease.
